Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950123-98-009281
Filing Date
1998-10-28
Accepted
1998-10-28 00:00:00
Documents
1
Group Members
JOHNSON & JOHNSONJOHNSON & JOHNSON DEVELOPMENT CORP
SROs
NYSE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 12380
  Complete submission text file 0000950123-98-009281.txt   14329
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 9085240400
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PKWY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-44055 | Film No.: 98731819
SIC: 2836 Biological Products, (No Diagnostic Substances)